Presentation TCT 2012 TCT-36. Circumferential Distribution of the Neointima Tissue at 6 Months and 2 at Years Follow-up After a Bioresorbable Scaffold Implantation: A Serial Optical Coherence... Presenter: Christos Bourantas October 23, 2012
Presentation TCT 2012 TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP) Presenter: Horst Sievert October 23, 2012
Presentation TCT 2012 TCT-85. Efficacy and Safety of Percutaneous Patent Foramen Ovale Closure in Patients with a Hypercoagulable Disorder Presenter: Ignacio Cruz-Gonz?lez October 23, 2012
Presentation TCT 2012 Radial Approach Offers No Benefit Over Femoral Plus Bivalirudin! Presenter: James Hermiller Jr October 23, 2012
Presentation TCT 2012 VESTAsync (MIV Therapeutics) Program Update Presenter: Ricardo Costa October 23, 2012
Presentation TCT 2012 Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress Presenter: Timothy Henry October 23, 2012
Presentation TCT 2012 TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention Presenter: Tim van de Hoef October 23, 2012
Presentation TCT 2012 TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions Presenter: Dierk Scheinert October 23, 2012
Presentation TCT 2012 State-of-the-Field Keynote: The Next Challenge: Improving Technical Efficiency and Biological Response (Nonresponders) Presenter: Deepak Bhatt October 23, 2012
Presentation TCT 2012 Management of the Device Patient for the Non-EP MD Presenter: Ralph Verdino October 23, 2012